Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Siri Weider has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Stian Lydersen

    Regional Centre for Child and Youth Mental Health and Child Welfare, Department of Mental Health, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway

    6 shared publications
  • Marit Sæbø Indredavik

    Regional Centre for Child and Youth Mental Health and Child Welfare, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Department of Child and Adolescent Psychiatry, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway

    4 shared publications
  • Anne Mari Sund

    Regional Centre for Child and Youth Mental Health and Child Welfare (RKBU), Department of Mental Health, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

    3 shared publications
  • Jan Stubberud

    Department of Research, Lovisenberg Diaconal Hospital, Oslo, Norway

    3 shared publications
  • Kaja Solland Egset

    Department of Psychology, Norwegian University of Science and Technology, Trondheim, Norway

    3 shared publications
  • Knut Hestad

    Department of Psychology, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

    3 shared publications

Latest Publications

  • Open Access

    Maybe if I lose another two kilos, something magical will happen: navigating food, body image, and weight among pre-elite cross-country skiers

    by Siri Weider, Ida Aarmo, Mari Bjerke Stranden, Celine Kormeseth-Rødal, Trond Nordfjærn, Tora Thorsrud

  • Open Access

    Association between body mass index and serum concentrations of olanzapine and selective serotonin reuptake inhibitors in patients with eating disorders

    by Vilde Hersleth, Olav Spigset, Siri Weider, Elise Koch, Ole A. Andreassen, Stian Lydersen, Katrine Kveli Fjukstad

    Purpose Selective serotonin reuptake inhibitors (SSRIs) and olanzapine are frequently prescribed for patients with anorexia nervosa and bulimia nervosa. The effect of severely low body mass index (BMI) on the pharmacokinetics of these drugs has received little attention. The aim was to investigate the association between BMI and dose-adjusted serum concentrations (concentration/dose ratios; CDRs) of SSRIs and olanzapine in patients with eating disorders. Method We conducted a retrospective analysis of patients from a regional center for eating disorders. BMI, daily doses of olanzapine and SSRIs, and their serum concentrations were obtained from medical records. Linear regression analyses were conducted with CDR for each drug as dependent variable and BMI as independent variable. A group of patients with schizophrenia or bipolar disorder was included for comparison of patients with BMI in the normal range. Results Sixty-five patients with eating disorders and 545 patients from the comparison group were included. Among the patients with eating disorders, there were no significant associations between BMI and CDRs for any of the drugs. CDR for olanzapine was significantly higher in the eating disorder group than in the comparison group, but most of this difference could be attributed to the higher proportion of smokers in the comparison group. Conclusion This study suggests that patients with eating disorders do not have clinically important changes in CDRs of SSRIs and olanzapine related to their low BMI. Although reassuring, the number of included patients treated with each drug is low.


  • Open Access

    Mental Distress, Fatigue and Executive Function in Adult Survivors of Childhood Leukemia and Non-Hodgkin Lymphoma

    by Anna R. Franzén, Jan Stubberud, Torstein B. Rø, Stian Lydersen, Kaja S. Egset, Ellen Ruud, Siri Weider, Mary-Elizabeth Eilertsen, Anne Mari Sund, Trude Reinfjell, et al.

    Survivors of childhood acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin lymphoma (NHL) are at risk of developing long-term adverse effects after survival. This study examined observed proportions of perceived mental distress, fatigue, and executive function (EF) impairment in adult childhood cancer survivors (CCSs) of ALL, AML, and NHL. Secondly, it examined the association between perceived EF impairment and mental distress or fatigue. Participants (n = 132; 57% female) were recruited from two major Norwegian hospitals. Self-report questionnaires included the Behavior Rating Inventory of Executive Function, Adult Version, the Hopkins Symptom Checklist-25, and the Fatigue Severity Scale. Proportions exceeding established clinical thresholds were calculated, and groups were compared using Pearson’s chi-squared test and Newcombe confidence intervals. Overall, 49% and 41% of participants met the clinical thresholds for depression and anxiety; 43% for fatigue; and 28% for EF impairment. Perceived EF impairment was significantly associated with mental distress and fatigue. Mental distress, fatigue, and EF impairment are commonly reported and distressing late effects among CCSs of ALL, AML, and NHL. Follow-up care focusing on neurocognitive and psychological outcomes is important for the long-term functioning and well-being of this survivor group. Targeted neurocognitive rehabilitation may represent a key component of follow-up care.

  • Open Access

    The impact of childhood sexual abuse and childhood traumatic events on outcome in adult inpatients with eating disorders

    by Siri Weider, Øyvind Rø, Sigrid Bjørnelv, Marit Danielsen

    Background: Childhood traumatic events (CTE) are frequently described in patients with eating disorders. However, the understanding of how such events impact eating disorder treatment outcome is limited. The aim of this study was to examine the prevalence of childhood sexual abuse (CSA) or any CTE at baseline in a naturalistic transdiagnostic sample, and to evaluate how such events affect symptom change and rates of remission at follow-up. Methods: The sample comprised 228 adult female former eating disorder inpatients (Mage = 24.6 years), of which 61.4% (n = 140) had been diagnosed with anorexia nervosa at baseline, 21.1% (n = 48) with bulimia nervosa, and 17.5% (n = 40) with other specified feeding or eating disorder including binge eating. Data on CSA/ CTE exposure were collected from the patients’ hospital records and were rated for degree of severity (severe, moderate to low, or no). Analyses of prevalence, group differences, and rates of remission at follow-up were performed. Results: Findings showed high prevalence of high severity CSA and CTE at admission, respectively 33% (n = 75) and 48.7% (n = 111). Moreover, although all patients showed significant improvement in symptoms from baseline to follow-up, a significant association was found between severity of CTE exposure and remission group affiliation with 24% of those with severe CTE exposure and 40% of those with no CTE exposure being in remission. Conclusions: Despite considerable heterogeneity in demographic characteristics, treatment and length of follow-up, severity of CTE exposure was associated with remission at follow-up. Thus, patients with the highest CTE severity showed the poorest prognoses. Findings from this study underline the importance of addressing trauma experiences in assessment and therapy and indicate that CTE severity level should be considered when assessing trauma experiences.


  • Open Access

    Transdiagnostic Cognitive Remediation Therapy for Patients with Eating Disorders: A Randomized Controlled Trial

    by Tora Thorsrud, Odin Hjemdal, Linda Thorsen, Nadia Micali, Camilla Lindvall Dahlgren, Siri Weider

    Background/Objectives: Eating disorders (EDs) are associated with cognitive inefficiencies related to cognitive flexibility, central coherence, and inhibition. Transdiagnostic cognitive remediation therapy (TCRT) is a new adaption of cognitive remediation therapy aimed at addressing these difficulties across ED diagnoses. This study investigates the effects of TCRT as an adjunctive treatment for patients with EDs on cognitive and clinical outcomes. Methods: A randomized controlled trial compared the effect of 9 individual sessions of TCRT in conjunction with treatment as usual (TAU) compared to TAU only for patients with EDs and concurrent cognitive difficulties. Participants were assessed at baseline, post-treatment (12 weeks after baseline), and follow-up (6 months after post-treatment assessment). The outcome measures included neuropsychological tests and self-report questionnaires measuring cognitive difficulties and ED psychopathology. The analysis was in accordance with intention to treat principles. Results: Sixty patients with various ED diagnosis and concurrent cognitive difficulties were recruited. The TCRT group (n = 30) displayed significantly greater improvement in self-reported executive functioning, measured by the Behavior Rating Inventory of Executive Function—Adult version compared to the control group (n = 30). However, no superiority of TCRT was observed on performance-based measures of set shifting, central coherence, or inhibition. Moreover, there was no significant difference in improvement in self-reported ED psychopathology. Conclusions: TCRT may enhance compensatory mechanisms for cognitive inefficiencies rather than improve cognitive effectiveness or ED symptoms directly for patients with EDs and concurrent cognitive difficulties. Further investigation of how these impact everyday functioning may provide valuable insights into TCRT’s role in ED treatment.


  • Open Access

    Food Avoidance and Aversive Goal Value Computation in Anorexia Nervosa

    by Siri Weider, Megan E. Shott, Tyler Nguyen, Skylar Swindle, Tamara Pryor, Lot C. Sternheim, Guido K. W. Frank

    Anorexia nervosa (AN) is associated with food restriction and significantly low body weight, but the neurobiology of food avoidance in AN is unknown. Animal research suggests that food avoidance can be triggered by conditioned fear that engages the anterior cingulate and nucleus accumbens. We hypothesized that the neural activation during food avoidance in AN could be modeled based on aversive goal value processing. Nineteen females with AN and thirty healthy controls matched for age underwent functional magnetic resonance brain imaging while conducting a food avoidance task. During active control free-bid and computer-generated forced-bid trials, participants bid money to avoid eating food items. Brain activation was parametrically modulated with the trial-by-trial placed bids. During free-bid trials, the AN group engaged the caudate nucleus, nucleus accumbens, ventral anterior cingulate, and inferior and medial orbitofrontal cortex more than the control group. High- versus low-bid trials in the AN group were associated with higher caudate nucleus response. Emotion dysregulation and intolerance of uncertainty scores were inversely associated with nucleus accumbens free-bid trial brain response in AN. This study supports the idea that food avoidance behavior in AN involves aversive goal value computation in the nucleus accumbens, caudate nucleus, anterior cingulate, and orbitofrontal cortex.


  • Open Access

    Neurocognitive outcome and associated factors in long-term, adult survivors of childhood acute lymphoblastic leukemia, treated without cranial radiation therapy

    by Kaja Solland Egset, Jan Stubberud, Ellen Ruud, Magnus Aassved Hjort, Mary-Elizabeth Bradley Eilertsen, Anne Mari Sund, Odin Hjemdal, Siri Weider, Trude Reinfjell

    Objective: There is limited research on neurocognitive outcome and associated risk factors in long-term, adult survivors of childhood acute lymphoblastic leukemia (ALL), without treatment of cranial radiation therapy. Moreover, the impact of fatigue severity and pain interference on neurocognition has received little attention. In this cross-sectional study, we examined neurocognitive outcome and associated factors in this population.Method: Intellectual abilities, verbal learning/memory, processing speed, attention, and executive functions were compared to normative means/medians with one sample t tests or Wilcoxon signed-rank tests. Associations with risk factors, fatigue severity, and pain interference were analyzed with linear regressions.Results: Long-term, adult survivors of childhood ALL (N = 53, 51% females, mean age = 24.4 years, SD = 4.4, mean = 14.7 years post-diagnosis, SD = 3.4) demonstrated above average intellectual abilities, but performed below average in attention, inhibition, processing speed, and shifting (p < 0.001). Executive functioning complaints were significantly higher than normative means, and positively associated with fatigue (p < 0.001). There was no interaction between sex and fatigue and no neurocognitive impairments were associated with pain interference, risk group, age at diagnosis, or sex.Conclusions: Long-term, adult survivors of ALL treated without cranial radiation therapy, demonstrate domain-specific performance-based neurocognitive impairments. However, continued research on the neurocognitive outcome in this population as they age will be important in the coming years. Executive functioning complaints were frequently in the clinical range, and often accompanied by fatigue. This suggests a need for cognitive rehabilitation programs.


  • Open Access

    Neurocognitive function and associations with mental health in adults born preterm with very low birthweight or small for gestational age at term

    by Siri Weider, Astrid M. W. Lærum, Kari Anne I. Evensen, Solveig Klæbo Reitan, Stian Lydersen, Ann Mari Brubakk, Jon Skranes, Marit S. Indredavik

    Objectives: To assess neurocognitive function in adults born with low birthweight compared with controls and to explore associations between neurocognitive function and psychopathology in these groups.Methods: In this prospective cohort study, one group born preterm with very low birthweight (VLBW: birthweight g, n = 53), one group born small for gestational age at term (SGA: birthweight n = 63) and one term-born control group (birthweight ≥10th percentile, n = 81) were assessed with neurocognitive tests, diagnostic interviews, and self-report questionnaires at 26 years of age.Results: The VLBW group scored significantly below the control group on several neurocognitive measures, including IQ measures, psychomotor speed, verbal fluency, aspects of visual learning and memory, attention, social cognition, working memory and fine motor speed. The SGA group consistently scored at an intermediate level between the VLBW and the control group and had significantly lower scores than controls on Performance IQ and psychomotor speed, including switching. In the VLBW group, associations were found between lower spatial working memory and the presence of anxiety disorders, internalizing and attention problems, and autistic traits. Furthermore, lower Full scale IQ was associated with attention problems when adjusting for sex and parental socioeconomic status.Conclusion: Adults born preterm with VLBW or born term SGA displayed neurocognitive difficulties. Spatial working memory was associated with difficulties with attention, anxiety, and social function of VLBW adults. The finding and its clinical applicability should be further explored.


  • Open Access

    Cognitive Rehabilitation for Neurocognitive Late Effects in Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Feasibility and Case-Series Study

    by Kaja Solland Egset, Siri Weider, Jan Stubberud, Odin Hjemdal, Ellen Ruud, Magnus Aassved Hjort, Mary-Elizabeth Bradley Eilertsen, Anne Mari Sund, Magnhild Eitrem Røkke, Trude Reinfjell

    Neurocognitive late effects following the diagnosis and treatment of childhood acute lymphoblastic leukemia (ALL) commonly include impaired executive functions (EFs), with negative consequences for one’s health-related quality of life and mental health. However, interventions for EF impairments are scarce. Thus, the aims of this study were to (1) explore the feasibility and acceptability of the cognitive rehabilitation program Goal Management Training (GMT) and (2) examine whether GMT is associated with positive outcomes across cases of ALL survivors with EF complaints. Four participants (median age 31.5 years) underwent nine GMT modules in a total of five group sessions. Rehabilitation was focused on compensatory strategies to improve real-life EFs. Participants were evaluated at 2-week and 6-month follow-ups. Evaluation of feasibility and acceptability included adherence, a semi structured interview, self-reports, and safety. Additionally, therapists’ experience with implementation was evaluated. Outcome measures included self-reports and neurocognitive tests of attention, EF, and processing speed. All participants completed GMT and rated the intervention as useful, suitable, and satisfactory. The reliable change index showed improved daily life EFs (two participants) and neurocognitive performance (three participants) at 6-month follow-up. Additionally, all participants improved on a “real-life” task involving EF. A future randomized controlled trial is recommended.